Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

LYN

RBC: LYN · Substrate: pEY · medium confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Ponatinib100.00.53
Dasatinib99.60.70
Tivozanib99.30.67
Bosutinib98.90.55
Repotrectinib98.70.61
Vandetanib98.00.72
Nintedanib97.90.61
Erdafitinib97.80.74
Ibrutinib95.70.72
Ripretinib95.30.67
Canertinib95.20.67
Gilteritinib93.70.51
Dacomitinib93.40.66
Pacritinib92.40.45
Alectinib92.40.65

Known variants

No variants catalogued.
Open in new tab